REVB
Revelation Biosciences, Inc.
There isn't enough reported data to score REVB yet.
REVB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
REVB's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
REVB PE Valuation
REVB has no meaningful PE right now: it lost money over the past year.
REVB Forward outlook
There aren't enough analyst estimates for REVB to show an outlook.
REVB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2022 | -$1,862,784.00 | -$284,320.11 |
| Q2 2022 | -$2,370,816.00 | -$1,385,056.11 |
REVB lost $1,683.77 per share over the past year, a smaller loss than the year before.
REVB Quarterly Revenue
REVB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$3.7M | -$1.7M |
| Q3 2024 | -$9.3M | -$7.6M |
| Q2 2024 | -$2.5M | -$487.1K |
| Q1 2024 | -$2.9M | -$1.3M |
| Q4 2021 | -$225.7K | -$19.2K |
REVB has burned cash in almost every quarter: −$12M over the past year, against −$17M the year before.
REVB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.3% | +12.5K shares |
| 1 year | +5756% | +550K shares |
| 3 years | +717331% | +560K shares |
| 5 years | +27979700% | +560K shares |
REVB has 559,596 diluted shares, up 5756% from a year ago.
REVB Net Leverage
REVB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
REVB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.6 | Oversold |
| Stochastic | 18.7 | Oversold |
REVB's weekly RSI is 29 (oversold) and its Stochastic is 19 (oversold).
REVB PE vs Healthcare Sector
REVB has no meaningful PE right now: it lost money over the past year.
REVB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.53 | 3.3% below |
| 20 week MA | $6.20 | 29% below |
| 50 week MA | $10.2 | 57% below |
| 100 week MA | $100.4 | 96% below |
| 200 week MA | $16,046.3 | 100% below |
REVB is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
REVB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $9,737,280.0 | $253,733.8 | -97% |
| 2023 | $253,733.8 | $20,188.2 | -92% |
| 2024 | $20,188.2 | $482.4 | -98% |
| 2025 | $482.4 | $24.1 | -95% |
| 2026 YTD | $24.1 | $4.38 | -82% |
REVB has finished every year since 2022 lower, and it's down 82% so far in 2026.